TCM
VCYT icon

Tuttle Capital Management’s Veracyte VCYT Stock Holding History

Tuttle Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-35,768
Closed -$948K – 243
2019
Q3 		$948K Buy
+35,768
New +$951K 0.25% 109

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Tuttle Capital Management's VCYT Position: Q4 2019 in Review

Tuttle Capital Management sold out of Veracyte (VCYT) in Q4 2019, closing a stake of 35,768 shares — an estimated $948K sold.

Tuttle Capital Management first reported a position in VCYT in Q3 2019 and held it in 1 quarter. The position peaked at $948K in Q3 2019. 179 funds tracked by Wall St. Rank hold VCYT as of Q4 2019.

  • Tuttle Capital Management reported no remaining Veracyte position as of Q4 2019 after selling out during the quarter.
  • Tuttle Capital Management sold 35,768 Veracyte shares in Q4 2019, an estimated $948K.
  • Tuttle Capital Management first reported a position in Veracyte in Q3 2019 and held it in 1 quarter.
  • Tuttle Capital Management's Veracyte position peaked at $948K in Q3 2019.
  • 179 funds tracked by Wall St. Rank held Veracyte as of Q4 2019.

Based on Tuttle Capital Management's 13F filing for Q4 2019, filed 13 Jan 2020.